Colombia Export Data for Bulk Pseudoephedrine Medicaments Under HS Code 300342
HS Code 300342 is officially defined as Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale : Other, containing alkaloids or derivatives thereof : Containing pseudoephedrine (INN) or its salts in Colombia. Colombia classifies these goods under the Nomenclatura Andina (NANDINA), which extends the 6-digit HS to 10 digits. Explore Colombia export shipment records for Bulk Pseudoephedrine Medicaments classified under HS Code 300342.
Latest Colombia Export Trade Records For Bulk Pseudoephedrine Medicaments Under HS Code 300342
As of 2026-07-20, companies recorded in Colombia export shipments of Bulk Pseudoephedrine Medicaments (HS Code 300342) include CI FARMACAPSULAS F, C I FARMACAPSULAS S A S F and FINDALER D, as declared on bill of lading trade records. These shipments are destined for CHILE. In 2024, Colombia's total export value for Bulk Pseudoephedrine Medicaments was US$ 133,985. Full shipment records include fields such as exporter, importer, country of origin, destination country, trade value, weight, quantity, and ports of loading and discharge.
Subscribe Now to run unlimited searches and unlock full shipment records, trade partners and trade metrics for Bulk Pseudoephedrine Medicaments under HS Code 300342.
1-10 of 8,200M+ Bill of Lading database covers import export Trade records updated till 2026-07-20
Access Full & Detailed Trade Data for HS Code 300342
Reveal full shipment records, buyers, suppliers and trade metrics for Bulk Pseudoephedrine Medicaments, and run unlimited searches across TradeInt global trade database.
Top Export Products Related to HS Code 300342 (Bulk Pseudoephedrine Medicaments) in Colombia
Based on Colombia export trade data, top export products related to HS Code 300342 in Colombia are:
Aggregated Colombia export data for 2024.